Blood Pressure Control, Diabetes, Glucose Control, Hypertension, Psychosocial Adaptation
Conditions
Brief summary
The Iinterdisciplinary collaborative care model combined with family empowerment (ICCM-FE) intervention based on the COM-B model can effectively improve blood pressure and glucose control in patients with comorbid hypertension and diabetes, enhance their quality of life and psychosocial adaptation, and significantly increase patient satisfaction with nursing care. This intervention has important clinical application value.
Detailed description
To evaluate the efficacy of an interdisciplinary collaborative care model combined with family empowerment (ICCM-FE) based on the COM-B model in managing comorbid hypertension and diabetes, focusing on its impact on blood pressure, glucose control, and psychosocial adaptation. This prospective randomized controlled trial (RCT) enrolled 187 patients with comorbid hypertension and diabetes from January 2023 to March 2024. Patients were randomly assigned to a control group (n = 93) receiving routine care and an observation group (n = 94) receiving ICCM-FE intervention. Follow-up was conducted over 6 months, assessing blood pressure (SBP and DBP), glucose levels (FPG and HbA1c), quality of life (SF-36 scale), psychosocial adaptation (PAIS-SR scale), and nursing satisfaction (NSNS scale) pre- and post-intervention.
Interventions
The observation group received interdisciplinary collaborative care and family empowerment (ICCM-FE) intervention based on the COM-B model on the basis of routine care.
The control group received routine nursing intervention, including basic drug treatment, diet and exercise guidance, psychological counseling, etc.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients met the diagnostic criteria for hypertension and diabetes as specified in the 《2020 International Society of Hypertension Global Hypertension Practice Guidelines》and the 《2020 American Diabetes Association (ADA) Standards of Medical Care in Diabetes》 ; * had at least one caregiver, and both the patient and caregiver had basic communication and comprehension abilities to cooperate with the nursing interventions and complete the questionnaires; * voluntarily participated in the study and signed an informed consent form; * complete follow-up records.
Exclusion criteria
* severe organ dysfunction or mental illness; * malignancies, severe cardiovascular events (e.g., stroke, myocardial infarction); * severe hepatic or renal impairment; * poor adherence or life expectancy less than 1 year.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Blood Pressure Control | Baseline and 6 months. | Change in systolic blood pressure (SBP) and diastolic blood pressure (DBP) from baseline to 6 months post-intervention. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Quality of Life (SF-36 Scale) | Baseline and 6 months | Change in SF-36 scores across eight domains (physical function, mental health, role limitations, etc.) from baseline to 6 months post-intervention. |
| Psychosocial Adaptation (PAIS-SR Scale) | Baseline and 6 months. | Change in psychosocial adjustment scores (healthcare orientation, occupational/family environment, psychological stress, etc.) from baseline to 6 months post-intervention. |
| Self-Efficacy (GSES Scale) | Baseline and 6 months. | Change in General Self-Efficacy Scale (GSES) scores from baseline to 6 months post-intervention. |
| Nursing Satisfaction (NSNS Scale) | 6 months. | Patient satisfaction with nursing care measured using the Newcastle Satisfaction with Nursing Services Scale (NSNS) at 6 months post-intervention. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Adherence to Intervention | Monthly for 6 months. | Compliance rates with the interdisciplinary collaborative care model (ICCM-FE) assessed via follow-up attendance and task completion logs. |
Countries
China